Cellomics Sells ArrayScan System to Vertex | GenomeWeb

NEW YORK, July 27- Cellomics, a Pittsburgh-based maker of cell-imaging technology, said recently that it sold its ArrayScan HCS System to Vertex Pharmaceuticals of Cambridge, Mass.

The ArrayScan Sytem is an automated system designed to measure and analyze cell activity as a way of determining function. The system can also be used to determine whether a drug is toxic or efficacious, Cellomics said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."